Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)

University of Toronto

$100,000.00

Regulation of Fungal Drug Resistance and Pathogenesis by Histone Deacetylases

FY 2009-10

Summary
Cancer patients and other individuals with reduced immune function, such as patients with HIV or those undergoing major surgery or organ transplantation, are vulnerable to life-threatening fungal infectious disease. Fungal infections are notoriously difficult to treat, in part because fungi are very similar to humans and it is challenging to identify drugs that kill the pathogen but not the host. The efficacy of antifungal drugs is compromised by the emergence of drug resistance. This research is focused on dissecting the molecular mechanisms by which fungi acquire drug resistance and cause disease through conserved cellular processes that are also implicated in the progression of cancer. This research will investigate how compromising two key cellular regulators affects the ability of the leading fungal pathogens of humans to survive exposure to the drugs that we use to kill them. Initial studies suggest that impairing these regulators renders resistant pathogens more responsive to treatment. This research will test the therapeutic potential of drugs that block the function of these regulators in models of fungal invasive disease. Fungi are very closely related to humans and share many of the same genes and cellular processes, but they are much simpler to work with from an experimental point of view. Thus, this research on dissecting the mechanisms by which these regulators work and influence cellular processes will not only illuminate key aspects of infectious disease but will also provide new insights into regulation important for cancer progression. Drugs that target the two key regulators that are the focus of this research are currently in clinical development as anti-cancer agents, thus this research will provide critical new understanding as to how these regulators work together to influence cancer progression and how they can be harnessed to treat the leading causes of fungal infectious disease-related deaths in imunocompromised individuals.
Program
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
199349
Name
Cowen Leah E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Regulation of Fungal Drug Resistance and Pathogenesis by Histone Deacetylases
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Keyworddelim
Antimicrobial Drug Resistance; Fungal Pathogenesis; Host-Pathogen Interaction; Infectious Disease; Microbial Evolution; Microbial Genomics
Abstract
Cancer patients and other individuals with reduced immune function, such as patients with HIV or those undergoing major surgery or organ transplantation, are vulnerable to life-threatening fungal infectious disease. Fungal infections are notoriously difficult to treat, in part because fungi are very similar to humans and it is challenging to identify drugs that kill the pathogen but not the host. The efficacy of antifungal drugs is compromised by the emergence of drug resistance. This research is focused on dissecting the molecular mechanisms by which fungi acquire drug resistance and cause disease through conserved cellular processes that are also implicated in the progression of cancer. This research will investigate how compromising two key cellular regulators affects the ability of the leading fungal pathogens of humans to survive exposure to the drugs that we use to kill them. Initial studies suggest that impairing these regulators renders resistant pathogens more responsive to treatment. This research will test the therapeutic potential of drugs that block the function of these regulators in models of fungal invasive disease. Fungi are very closely related to humans and share many of the same genes and cellular processes, but they are much simpler to work with from an experimental point of view. Thus, this research on dissecting the mechanisms by which these regulators work and influence cellular processes will not only illuminate key aspects of infectious disease but will also provide new insights into regulation important for cancer progression. Drugs that target the two key regulators that are the focus of this research are currently in clinical development as anti-cancer agents, thus this research will provide critical new understanding as to how these regulators work together to influence cancer progression and how they can be harnessed to treat the leading causes of fungal infectious disease-related deaths in imunocompromised individuals.
Competitiondate
200909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cowen, Leah E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~